Počet záznamů: 1
Interferon gamma release assay has potential in the prediction of chronic graft-versus-host disease in recipients of myeloablative allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis
- 1.0013747 2026 RIV NL eng J
Šťastná Marková, Markéta - Pecherková, Pavla - Němečková, Šárka - Kryštofová, Jitka - Vaníková, Šárka - Vydra, Jan - Roubalová, KateřinaG
Interferon gamma release assay has potential in the prediction of chronic graft-versus-host disease in recipients of myeloablative allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis.
Transplant immunology. Vol. 88, no. February (2025) art. no. 102166. ISSN 0966-3274
Grant: Ministerstvo zdravotnictví NU22-E-138
Institucionální podpora: RVO:00023736
Klíčová slova: AML * GVHD prophylaxis * MDS
Cite Score: 2.800, rok: 2024; SJR: 0.458, rok: 2024; IF: 1.4, rok: 2024
DOI: 10.1016/j.trim.2024.102166
Počet záznamů: 1